EUVIMED · CrossrefJournal
Journal of Crohn's and Colitis
ISSN 1873-9946 · Oxford University Press (OUP)
Latest articles
The risk of mild, moderate, and severe infections in inflammatory bowel disease patients—a prospective, multicenter observational cohort study
ECCO Topical Review: Inflammatory Bowel Disease-Like Patterns of Drug Colitis with Practical Guidance and a Focus on Immune Checkpoint Inhibitor-Induced Enterocolitis
Microbial and antimicrobial resistance signatures differentiate healthy and inflamed ileal pouches in patients with ulcerative colitis
Treatment patterns and determinants of persistence with advanced therapies in adults with newly diagnosed Crohn’s disease: an interim analysis of an inception cohort registry study (iCREST-CD)
Correction: Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
B cell/adipocyte crosstalk amplifies MCP-1 secretion, M2-like macrophage accumulation, and polarization in gut-associated, inflamed adipose tissue
Value of non-contrast magnetic resonance imaging for diagnosis of perianal fistulas in Crohn’s disease
Serum MMP-10 levels predict incident inflammatory bowel disease: an observational analysis from the PURE study
Risk of perianal penetrating complications among adult patients with non-penetrating Crohn’s disease initiating advanced therapies: a retrospective cohort study
ECCO Topical Review on Optimisation of Therapy for Inflammatory Bowel Disease
Longitudinal timepoint assessment of patient-reported clinical disease activity in ulcerative colitis and Crohn’s disease: suitability of a rapid Patient-Reported Outcome 2 (PRO-2) assessment
Interpretable machine learning models for early prediction of Crohn’s disease and ulcerative colitis in a nationwide health system
Prevalence and epidemiologic features of adult upper gastrointestinal Crohn’s disease over the last 30 years: a scoping review
Outcomes of endoscopic balloon dilatation for de novo and anastomotic Crohn’s strictures: a Canadian tertiary center experience
Cyclosporine A in acute severe ulcerative colitis: practical considerations for dosing, monitoring, and prophylaxis
Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study
Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes
Management of Pediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group
Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression
Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn’s disease—the MILESTONE-CD prospective cohort
Clinical outcomes following switch from risankizumab to guselkumab in Crohn’s disease
Automated AI-based Mayo Endoscopic Scoring for ulcerative colitis across adult and pediatric cohorts from diverse populations
Correction to: Rapid resolution of colon inflammation and microbiome remodeling with vancomycin therapy in a patient with primary sclerosing cholangitis
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Dietary emulsifiers and host inflammation synergistically drive genomic evolution of Crohn’s disease-associated Escherichia coli toward enhanced pathogenicity
Off-label upadacitinib 60 mg daily in the rescue of refractory ulcerative colitis: an open-labeled cohort study
Correction to 5 papers to correct the issue number
Intestinal cancer risk in Crohn’s disease: authors’ reply on methods, data integrity, and clinical implications
EUVIMED